Directorate Change
6 March 2017 07:00 GMT CHANGES TO ASTRAZENECA BOARD OF DIRECTORS AstraZeneca today announced that Philip Broadley will be proposed to shareholders for election as a Non-Executive Director of AstraZeneca PLC at the Company's Annual General Meeting (AGM) on 27 April 2017. On election, the Board proposes appointing Mr Broadley as a member of the Audit Committee. Ann Cairns, a Non-Executive Director, will step down from the AstraZeneca Board and as a member of the Audit Committee with effect from the end of the AGM on 27 April 2017. Leif Johansson, Chairman of AstraZeneca, said: "On